| Net Cash Provided by (Used in) Operating Activities |
-108K |
USD |
-372% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
100K |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500M |
shares |
-93.3% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
20.5M |
shares |
-93.1% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-8.14K |
USD |
+64.4% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6.44K |
USD |
-68.7% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
1.98M |
USD |
+5.49% |
Q2 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-735K |
USD |
-432% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
9.27M |
USD |
+6.03% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
42.7K |
USD |
-4.38% |
Q3 2025 |
Q1 2026 |